UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

Journal of neuroinflammation, 2011-08, Vol.8 (1), p.92-92, Article 92

2011

Volltextzugriff (PDF)

Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer’s Risk Genes Via Suppression of TLR4 Signaling

Journal of molecular neuroscience, 2021-06, Vol.71 (6), p.1245-1255

2021

Volltextzugriff (PDF)

The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice

Behavioural brain research, 2012-02, Vol.227 (1), p.36-42

2012

Volltextzugriff (PDF)

Isoform-Specific Enhancement of Adenylyl Cyclase Activity by n-Alkanols

Alcoholism, clinical and experimental research, 2007-09, Vol.31 (9), p.1467-1472

2007

Volltextzugriff (PDF)

Catalytic Immunoglobulin Gene Delivery in a Mouse Model of Alzheimer’s Disease: Prophylactic and Therapeutic Applications

Molecular neurobiology, 2015-02, Vol.51 (1), p.43-56

2015

Volltextzugriff (PDF)

Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations

Brain research, 2010-10, Vol.1356, p.102-111

2010

Volltextzugriff (PDF)

Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP

Toxicology letters, 2007-07, Vol.171 (3), p.154-161

2007

Volltextzugriff (PDF)

Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression

Biochemical and biophysical research communications, 2016-10, Vol.479 (2), p.331-337

2016

Volltextzugriff (PDF)

Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer’s disease

Brain, behavior, and immunity, 2017-10, Vol.65, p.262-273

2017

Volltextzugriff (PDF)

MyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease

The American journal of pathology, 2011-09, Vol.179 (3), p.1095-1103

2011

Volltextzugriff (PDF)

Neurotoxicity in murine striatal dopaminergic pathways following co-application of permethrin, chlorpyrifos, and MPTP

Pesticide biochemistry and physiology, 2006-06, Vol.85 (2), p.68-75

2006

Volltextzugriff (PDF)

Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway

Brain, behavior, and immunity, 2016-03, Vol.53, p.84-95

2016

Volltextzugriff (PDF)

P4‐206: Molecular mechanism of microglial dysfunction in a mouse model of Alzheimer's disease

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_18), p.P859-P860

2015

Volltextzugriff (PDF)

Molecular mechanism of microglial dysfunction in a mouse model of Alzheimer’s disease

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P859-P860

2015

Volltextzugriff (PDF)

Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model

Journal of Alzheimer's disease, 2011-01, Vol.27 (1), p.23-38

2011

Volltextzugriff (PDF)

Muscle-Directed Anti-Aβ Single-Chain Antibody Delivery via AAV1 Reduces Cerebral Aβ Load in an Alzheimer’s Disease Mouse Model

Journal of molecular neuroscience, 2013-02, Vol.49 (2), p.277-288

2013

Volltextzugriff (PDF)

Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease

Journal of neuroimmunology, 2012-03, Vol.244 (1), p.70-83

2012

Volltextzugriff (PDF)

P2–407: Expression of an anti‐beta‐amyloid catalytic antibody by AAV9‐mediated gene delivery effectively prevents and reduces amyloid deposition in an Alzheimer's disease mouse model

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_12), p.P507-P507

2013

Volltextzugriff (PDF)

Expression of an anti-beta-amyloid catalytic antibody by AAV9-mediated gene delivery effectively prevents and reduces amyloid deposition in an Alzheimer's disease mouse model

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P507-P507

2013

Volltextzugriff (PDF)

Simvastatin enhances immune responses to Ab vaccination and attenuates vaccination-induced behavioral alterations

Brain research, 2010-10, Vol.1356, p.102-111

2010

Volltextzugriff (PDF)

Muscle-Directed Anti-A[beta] Single-Chain Antibody Delivery via AAV1 Reduces Cerebral A[beta] Load in an Alzheimer's Disease Mouse Model

Journal of molecular neuroscience, 2013-02, Vol.49 (2), p.277

2013

Volltextzugriff (PDF)

Expression of anti-Aβ single-chain antibody in skeletal muscle reduces Aβ accumulation in an Alzheimer's disease mouse model

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P186-P187

2012

Volltextzugriff (PDF)

P1‐227: Expression of anti‐Aβ single‐chain antibody in skeletal muscle reduces Aβ accumulation in an Alzheimer's disease mouse model

Alzheimer's & dementia, 2012-07, Vol.8 (4S_Part_5), p.P186-P187

2012

Volltextzugriff (PDF)

TLR4 mutation reduces microglial activation, increases A[beta] deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

Journal of neuroinflammation, 2011-08, Vol.8, p.92

2011

Volltextzugriff (PDF)

Simvastatin facilitates Abeta immunotherapy in mice

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S590-S590

2010

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer’s Risk Genes Via Suppression of TLR4 Signaling

The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice

Isoform-Specific Enhancement of Adenylyl Cyclase Activity by n-Alkanols

Catalytic Immunoglobulin Gene Delivery in a Mouse Model of Alzheimer’s Disease: Prophylactic and Therapeutic Applications

Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations

Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP

Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression

Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer’s disease

MyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease

Neurotoxicity in murine striatal dopaminergic pathways following co-application of permethrin, chlorpyrifos, and MPTP

Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway

P4‐206: Molecular mechanism of microglial dysfunction in a mouse model of Alzheimer's disease

Molecular mechanism of microglial dysfunction in a mouse model of Alzheimer’s disease

Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model

Muscle-Directed Anti-Aβ Single-Chain Antibody Delivery via AAV1 Reduces Cerebral Aβ Load in an Alzheimer’s Disease Mouse Model

Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease

P2–407: Expression of an anti‐beta‐amyloid catalytic antibody by AAV9‐mediated gene delivery effectively prevents and reduces amyloid deposition in an Alzheimer's disease mouse model

Expression of an anti-beta-amyloid catalytic antibody by AAV9-mediated gene delivery effectively prevents and reduces amyloid deposition in an Alzheimer's disease mouse model

Simvastatin enhances immune responses to Ab vaccination and attenuates vaccination-induced behavioral alterations

Muscle-Directed Anti-A[beta] Single-Chain Antibody Delivery via AAV1 Reduces Cerebral A[beta] Load in an Alzheimer's Disease Mouse Model

Expression of anti-Aβ single-chain antibody in skeletal muscle reduces Aβ accumulation in an Alzheimer's disease mouse model

P1‐227: Expression of anti‐Aβ single‐chain antibody in skeletal muscle reduces Aβ accumulation in an Alzheimer's disease mouse model

TLR4 mutation reduces microglial activation, increases A[beta] deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

Simvastatin facilitates Abeta immunotherapy in mice

Suchergebnisse filtern